Regional Analysis

Global DNA Sequencing Market- Regional Analysis

Among region, North America is expected to dominate the market over the forecast period. This is attributed to increasing adoption of organic growth strategies such as product launches by key players in the region to expand their product portfolio is expected to drive the market growth over the forecast period. For instance, in February 2021, Agilent Technologies Inc., a pharmaceutical company, announced the launch of the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit, intended for the qualitative detection of immunoglobulin G (IgG) antibodies attached to SARS-CoV-2 in human serum or plasma.

The Europe region is expected to be the second largest region over the forecast period, owing to increasing adoption of organic growth strategies such as product launches by key players in the region to expand product portfolio is expected to drive the market growth over the forecast period. For instance, in December 2021, F. Hoffmann-La Roche Ltd, a Switzerland based pharmaceutical company, announced the launched of the AVENIO Edge System, to deliver a fully-automated, integrated sequencing solution. The AVENIO Edge System is a pre-analytical platform for sequencing library preparation, target enrichment and quantification steps that deliver integrated, end-to-end control with reliable, and consistent high-quality results.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa